Hopp til hovedinnhold

Nevrofibromatose

Sist oppdatert: Sist revidert:
Sist revidert av:


Uptodate

BMJ best practise

  1. Blakeley JO, Plotkin SR. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro Oncol. 2016; 18(5): 624-38. pmid:26851632 PubMed  
  2. Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2014; Aug;13(8): 834-43.. pmid:25030515 PubMed  
  3. Friedman JM. Neurofibromatosis 1.In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews® Internet. Seattle (WA): University of Washington, Seattle; 1993-2017.1998 Oct 2 updated 2017 Nov 2.PMID: 20301288 PubMed  
  4. Hamed Al-Farsi FA, Said Al-Alyani OB, Al-Kumzari A, Al-Saadi T. Systemic review and meta-analysis of the intellectual integrity of children with Neurofibromatosis type 1 (NF-1). World Neurosurg. 2021 Oct 11:S1878-8750(21)01578-3. PMID: 34648986. PubMed  
  5. Rabab'h O, Gharaibeh A, Al-Ramadan A, Ismail M, Shah J. Pharmacological Approaches in Neurofibromatosis Type 1-Associated Nervous System Tumors. Cancers (Basel). 2021 Aug 1;13(15):3880. PMID: 34359780 PubMed  
  6. Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007; 61: 189-98. pmid:17387725 PubMed  
  7. Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. . Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skeletal Radiol 2020. pmid:31396668 PubMed  
  8. Tidsskr Nor Laegeforen. 2009 Aug 13;129(15):1469-73. doi: 10.4045/tidsskr.08.0151.Neurofibromatosis type 2 and auditory brainstem implantation.Article in NorwegianElvsåshagen T, Solyga V, Bakke SJ, Heiberg A, Kerty E. PMID: 19690597 PubMed  
  9. Slattery WH. Neurofibromatosis type 2. Otolaryngol Clin North Am. 2015 Jun;48(3):443-60 . pmid:26043141 PubMed  
  10. Tiwari R, Singh AK. Neurofibromatosis Type 2. 2022 Oct 3. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 29261934. PubMed  
  11. Robertson JA, Tallantyre EC. Nerve sheath tumours. J Neurol. 2018 Dec;265(12):3034-3035. PMID: 30382390 PubMed  
  12. Farschtschi S, Merker VL, Wolf D, Schuhmann M, Blakeley J, Plotkin SR, Hagel C, Mautner VF. Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2. Acta Neurol Scand. 2015 Sep 15 . pmid:26369495 PubMed  
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Unn Ljøstad, spesialist i nevrologi, professor PhD